title: Progressive sclerodermoid skin changes--quiz case.
authors.affiliation: University of Texas Medical Branch, Galveston, TX, USA.
authors.forename: Mara M
authors.initials: MM
authors.lastname: Dacso
authors.forename: Matthew S
authors.initials: MS
authors.lastname: Petitt
authors.forename: Alma C
authors.initials: AC
authors.lastname: Berlingeri-Ramos
authors.forename: Brent C
authors.initials: BC
authors.lastname: Kelly
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016393:Lymphoma, B-Cell / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab; D012594:Scleroderma, Localized / Q000209:etiology*; D019043:Vascular Neoplasms / Q000150:complications / Q000473:pathology*; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone